108 related articles for article (PubMed ID: 9921651)
1. Increased expression of the LAZ3 (BCL6) proto-oncogene accompanies murine skeletal myogenesis.
Albagli-Curiel O; Dhordain P; Lantoine D; Auradé F; Quief S; Kerckaert JP; Montarras D; Pinset C
Differentiation; 1998 Nov; 64(1):33-44. PubMed ID: 9921651
[TBL] [Abstract][Full Text] [Related]
2. The LAZ3/BCL6 oncogene encodes a sequence-specific transcriptional inhibitor: a novel function for the BTB/POZ domain as an autonomous repressing domain.
Deweindt C; Albagli O; Bernardin F; Dhordain P; Quief S; Lantoine D; Kerckaert JP; Leprince D
Cell Growth Differ; 1995 Dec; 6(12):1495-503. PubMed ID: 9019154
[TBL] [Abstract][Full Text] [Related]
3. The proto-oncogene Bc16 inhibits apoptotic cell death in differentiation-induced mouse myogenic cells.
Kumagai T; Miki T; Kikuchi M; Fukuda T; Miyasaka N; Kamiyama R; Hirosawa S
Oncogene; 1999 Jan; 18(2):467-75. PubMed ID: 9927203
[TBL] [Abstract][Full Text] [Related]
4. Overexpressed BCL6 (LAZ3) oncoprotein triggers apoptosis, delays S phase progression and associates with replication foci.
Albagli O; Lantoine D; Quief S; Quignon F; Englert C; Kerckaert JP; Montarras D; Pinset C; Lindon C
Oncogene; 1999 Sep; 18(36):5063-75. PubMed ID: 10490843
[TBL] [Abstract][Full Text] [Related]
5. Nonrandom fusion of L-plastin(LCP1) and LAZ3(BCL6) genes by t(3;13)(q27;q14) chromosome translocation in two cases of B-cell non-Hodgkin lymphoma.
Galiègue-Zouitina S; Quief S; Hildebrand MP; Denis C; Detourmignies L; Laï JL; Kerckaert JP
Genes Chromosomes Cancer; 1999 Oct; 26(2):97-105. PubMed ID: 10469447
[TBL] [Abstract][Full Text] [Related]
6. The BTB/POZ domain targets the LAZ3/BCL6 oncoprotein to nuclear dots and mediates homomerisation in vivo.
Dhordain P; Albagli O; Ansieau S; Koken MH; Deweindt C; Quief S; Lantoine D; Leutz A; Kerckaert JP; Leprince D
Oncogene; 1995 Dec; 11(12):2689-97. PubMed ID: 8545127
[TBL] [Abstract][Full Text] [Related]
7. Small deletions occur in highly conserved regions of the LAZ3/BCL6 major translocation cluster in one case of non-Hodgkin's lymphoma without 3q27 translocation.
Bernardin F; Collyn-d'Hooghe M; Quief S; Bastard C; Leprince D; Kerckaert JP
Oncogene; 1997 Feb; 14(7):849-55. PubMed ID: 9047392
[TBL] [Abstract][Full Text] [Related]
8. Expression of the BCL6 gene in the pre- and postnatal mouse.
Bajalica-Lagercrantz S; Piehl F; Farnebo F; Larsson C; Lagercrantz J
Biochem Biophys Res Commun; 1998 Jun; 247(2):357-60. PubMed ID: 9642131
[TBL] [Abstract][Full Text] [Related]
9. Colocalization and heteromerization between the two human oncogene POZ/zinc finger proteins, LAZ3 (BCL6) and PLZF.
Dhordain P; Albagli O; Honore N; Guidez F; Lantoine D; Schmid M; The HD; Zelent A; Koken MH
Oncogene; 2000 Dec; 19(54):6240-50. PubMed ID: 11175338
[TBL] [Abstract][Full Text] [Related]
10. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells.
Phan RT; Dalla-Favera R
Nature; 2004 Dec; 432(7017):635-9. PubMed ID: 15577913
[TBL] [Abstract][Full Text] [Related]
11. Characterization of t(3;6)(q27;p21) breakpoints in B-cell non-Hodgkin's lymphoma and construction of the histone H4/BCL6 fusion gene, leading to altered expression of Bcl-6.
Kurata M; Maesako Y; Ueda C; Nishikori M; Akasaka T; Uchiyama T; Ohno H
Cancer Res; 2002 Nov; 62(21):6224-30. PubMed ID: 12414651
[TBL] [Abstract][Full Text] [Related]
12. Novel BTB/POZ domain zinc-finger protein, LRF, is a potential target of the LAZ-3/BCL-6 oncogene.
Davies JM; Hawe N; Kabarowski J; Huang QH; Zhu J; Brand NJ; Leprince D; Dhordain P; Cook M; Morriss-Kay G; Zelent A
Oncogene; 1999 Jan; 18(2):365-75. PubMed ID: 9927193
[TBL] [Abstract][Full Text] [Related]
13. Enhanced expression of mouse c-ski accompanies terminal skeletal muscle differentiation in vivo and in vitro.
Namciu S; Lyons GE; Micales BK; Heyman HC; Colmenares C; Stavnezer E
Dev Dyn; 1995 Nov; 204(3):291-300. PubMed ID: 8573720
[TBL] [Abstract][Full Text] [Related]
14. Ambivalent role of BCL6 in cell survival and transformation.
Albagli-Curiel O
Oncogene; 2003 Jan; 22(4):507-16. PubMed ID: 12555064
[TBL] [Abstract][Full Text] [Related]
15. Involvement of BCL6 in chromosomal aberrations affecting band 3q27 in B-cell non-Hodgkin lymphoma.
Chaganti SR; Chen W; Parsa N; Offit K; Louie DC; Dalla-Favera R; Chaganti RS
Genes Chromosomes Cancer; 1998 Dec; 23(4):323-7. PubMed ID: 9824205
[TBL] [Abstract][Full Text] [Related]
16. Denervation of mouse skeletal muscle differentially affects the expression of the jun and fos proto-oncogenes.
Bessereau JL; Fontaine B; Changeux JP
New Biol; 1990 Apr; 2(4):375-83. PubMed ID: 2126956
[TBL] [Abstract][Full Text] [Related]
17. Target genes downregulated by the BCL-6/LAZ3 oncoprotein in mouse Ba/F3 cells.
Hosokawa Y; Maeda Y; Seto M
Biochem Biophys Res Commun; 2001 May; 283(3):563-8. PubMed ID: 11341761
[TBL] [Abstract][Full Text] [Related]
18. Acetylation inactivates the transcriptional repressor BCL6.
Bereshchenko OR; Gu W; Dalla-Favera R
Nat Genet; 2002 Dec; 32(4):606-13. PubMed ID: 12402037
[TBL] [Abstract][Full Text] [Related]
19. The proto-oncogene BCL-6 is expressed in olfactory sensory neurons.
Otaki JM; Fearon DT; Yamamoto H
Neurosci Res; 2005 Oct; 53(2):189-200. PubMed ID: 16055217
[TBL] [Abstract][Full Text] [Related]
20. The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation.
Ye BH; Cattoretti G; Shen Q; Zhang J; Hawe N; de Waard R; Leung C; Nouri-Shirazi M; Orazi A; Chaganti RS; Rothman P; Stall AM; Pandolfi PP; Dalla-Favera R
Nat Genet; 1997 Jun; 16(2):161-70. PubMed ID: 9171827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
